Clinical Trials List
2008-10-01 - 2012-04-30
Phase III
Study ended7
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- 邱健泰 Division of Obstetrics & Gynecology
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Huei-Jean Huang Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- 黃寬仁 Division of Obstetrics & Gynecology
- Tzu-I Wu Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Yu-Fang Huang Division of Obstetrics & Gynecology
- Meng-Ru Shen Division of Obstetrics & Gynecology
- 鄭雅敏 Division of Obstetrics & Gynecology
- Keng-Fu Hsu Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 周松男 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Wei-Chun Chang Division of Obstetrics & Gynecology
- Huey-Yi Chen Division of Obstetrics & Gynecology
- Wu-Chou Lin Division of Obstetrics & Gynecology
- Yao-Ching Hung Division of Obstetrics & Gynecology
- Yin-Yi Chang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
360 participants
